The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Treatment of Malignant Pericardial Effusion
Abstract
OBJECTIVE: To discuss the diagnosis and treatment of malignant pericardial effusion and focus on quantitating the success and complication rates of the many treatment modalities and updating recent advances in the field. DATA SOURCES: English-language publications were identified by a computerized search (MEDLINE) of these key words: cancer, tumor, malignancy, pericardium, and pericardial effusion. This computerized search was supplemented by a manual search of the bibliographies of original research articles and textbooks. STUDY SELECTION: Studies were included if the outcome of patients undergoing treatment for malignant pericardial effusion was reported separately from the outcome of patients with other causes of pericardial effusions. Studies that only reported the combined results of patients with malignant and nonmalignant effusions were excluded. DATA EXTRACTION: To determine success rates for the various treatment modalities, we examined freedom from symptomatic recurrence of pericardial effusion requiring reintervention as the key end point. Where appropriate, we also examined procedural mortality rates. RESULTS: Initial relief of symptoms is achieved in most cases with percutaneous pericardiocentesis that, with echocardiographic guidance, can be performed with low morbidity and mortality. In many cases, drainage for several days with an indwelling catheter alleviates the effusion without subsequent recurrence. Systemic antitumor therapy with chemotherapy or radiation therapy is effective in controlling malignant effusions in cases of sensitive tumors such as lymphomas, leukemias, and breast cancer. Local sclerotherapy with tetracycline hydrochloride or bleomycin sulfate is also effective and associated with low morbidity. Sclerotherapy with other agents or radionuclides offers no advantages. Of the several surgical options, subxiphoid pericardiotomy has the advantage of low morbidity and mortality, can often be performed under local anesthesia, and is highly effective in preventing recurrence. Percutaneous balloon pericardiotomy has recently been described. This intervention is performed with local anesthesia, is effective in preventing reaccumulation, and has a low morbidity. CONCLUSIONS: Treatment of malignant pericardial effusions must be individualized with consideration given to the patient's condition and tumor type, the success rates and risks of the various modalities, and local availability and expertise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
USE OF NITROGEN MUSTARD IN TREATMENT OF SEROUS EFFUSIONS OF NEOPLASTIC ORIGIN
Weisberger, A. S., Levine, B., & Storaasli, J. P. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960350004002 · Cited by 182
Piehler, J. M., Pluth, J. R., Schaff, H. V., et al. (1985) · PubMed · Cited by 163
Pericardial disease in patients with cancer
Posner, M. R., Cohen, G. I., & Skarin, A. T. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90168-6 · Cited by 153
Management of Acute Cardiac Tamponade by Subxiphoid Pericardiotomy
Alcan, K. E. (1982) · JAMA · doi:10.1001/jama.1982.03320330039023 · Cited by 92
Intracavitary 5-Fluorouracil in Malignant Effusions
Suhrland, L. G. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870030111019 · Cited by 74
The Role of Cytology in the Evaluation of Pericardial Effusions
Zipf, R. E., & Johnston, W. W. (1972) · CHEST Journal · doi:10.1378/chest.62.5.593 · Cited by 52
Cited by
2015 ESC Guidelines for the diagnosis and management of pericardial diseases
Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., Brucato, A., Gueret, P., Klingel, K., Lionis, C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv318 · Cited by 2,634
Bussani, R., De-Giorgio, F., Abbate, A., & Silvestri, F. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035105 · Cited by 642
TSANG, T. S. M., ENRIQUEZ-SARANO, M., FREEMAN, W. K., BARNES, M. E., SINAK, L. J., GERSH, B. J., BAILEY, K. R., & SEWARD, J. B. (2002) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62211-8 · Cited by 536
Troughton, R. W., Asher, C. R., & Klein, A. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15648-1 · Cited by 430
Metadata
- Authors
- Vaitkus, P. T.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1994-07-06
- Volume
- 272
- Issue
- 1
- Pages
- 59
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1966112821
- Cited by
- 297
- References
- 6
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Malignant Pericardial Effusion. https://app.cochat.ai/papers/10.1001/jama.1994.03520010071035
- The paper
- Vaitkus, P. T. (1994). Treatment of Malignant Pericardial Effusion. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1994.03520010071035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.